Based on the analysis results above, we discovered that the transcriptional level of EIF3B in breast cancer tissues was higher than that of para-carcinoma tissues, and over-expressed EIF3B indicated poor survival showed a consistent trend among the above databases and suggested it as an oncogene. This evidence concerns the gene EIF3B and breast carcinoma.